Bank of America’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $121K | Sell |
31,721
-4,474
|
|
||||
2025
Q1 | $95.2K | Sell |
36,195
-7,842
|
|
||||
2024
Q4 | $156K | Buy |
44,037
+3,647
|
|
||||
2024
Q3 | $184K | Buy |
40,390
+2,474
|
|
||||
2024
Q2 | $165K | Buy |
37,916
+9,637
|
|
||||
2024
Q1 | $142K | Sell |
28,279
-4,295
|
|
||||
2023
Q4 | $204K | Buy |
32,574
+14,952
|
|
||||
2023
Q3 | $125K | Sell |
17,622
-1,452
|
|
||||
2023
Q2 | $194K | Buy |
19,074
+5,912
|
|
||||
2023
Q1 | $119K | Buy |
13,162
+12,134
|
|
||||
2022
Q4 | $7.37K | Buy |
1,028
+28
|
|
||||
2022
Q3 | $7K | Hold |
1,000
|
|
||||
2022
Q2 | $5K | Sell |
1,000
-39
|
|
||||
2022
Q1 | $6K | Sell |
1,039
-133
|
|
||||
2021
Q4 | $6K | Buy |
1,172
+18
|
|
||||
2021
Q3 | $8K | Sell |
1,154
-339
|
|
||||
2021
Q2 | $9K | Sell |
1,493
-6,771
|
|
||||
2021
Q1 | $55K | Buy |
8,264
+3,547
|
|
||||
2020
Q4 | $25K | Buy |
4,717
+697
|
|
||||
2020
Q3 | $30K | Buy |
4,020
+81
|
|
||||
2020
Q2 | $29K | Buy |
3,939
+1,210
|
|
||||
2020
Q1 | $20K | Buy |
+2,729
|
|
||||
2019
Q4 | – | Sell |
-742
|
|
||||
2019
Q3 | $4K | Sell |
742
-4,233
|
|
||||
2019
Q2 | $16K | Buy |
4,975
+944
|
|
||||
2019
Q1 | $12K | Sell |
4,031
-3,092
|
|
||||
2018
Q4 | $27K | Buy |
7,123
+1,924
|
|
||||
2018
Q3 | $31K | Buy |
5,199
+1,709
|
|
||||
2018
Q2 | $20K | Buy |
3,490
+2,944
|
|
||||
2018
Q1 | $7K | Sell |
546
-71
|
|
||||
2017
Q4 | $7K | Buy |
+617
|
|